1 November 2007 Path-length-resolved optical Doppler perfusion monitoring
Author Affiliations +
J. of Biomedical Optics, 12(6), 060508 (2007). doi:10.1117/1.2823141
Abstract
We report the first path-length-resolved perfusion measurements on human skin measured with a phase-modulated low-coherence Mach-Zehnder interferometer with spatially separated fibers for illumination and detection. Optical path lengths of Doppler shifted and unshifted light and path-length-dependent Doppler broadening of multiply scattered light from skin are measured from the Doppler broadened interference peaks appearing in the power spectrum. Perfusion and its variations during occlusion are measured in real time for a given optical path length, and the results are compared with the perfusion signal obtained with a conventional laser Doppler perfusion monitor.
Varghese, Rajan, Van Leeuwen, and Steenbergen: Path-length-resolved optical Doppler perfusion monitoring

The poorly established and biologically uncertain scattering and absorption properties of tissue often complicate noninvasive optical diagnosis in turbid tissues. For instance, in laser Doppler perfusion monitor (LDPM), the mean number of interactions with red blood cells depends on the paths traversed by the detected photons as they penetrate the tissue, and perfusion values averaged over different and basically unknown path lengths are measured.1 The depth of light penetration in the tissue depends on the wavelength of the light source, the distance between the transmitting and receiving fibers, and the optical properties of the tissue. This dependence leads to uncertainties in interpreting the Doppler shifted and nonshifted fraction of photons and also in discriminating the fraction of light scattered from superficial (nutrient) and deeper (thermoregulatory) layers of skin. As such, depth-resolved perfusion information could be obtained by multiwavelength systems,2, 3, 4 by varying the distance between transmitting and receiving fibers,5 or by using a multichannel laser Doppler probe.6 A multiwavelength laser system relies on short wavelength lasers, which are bulky, expensive, and difficult to stabilize.4 An alternate approach to depth discrimination based on coherence modulation of semiconductor lasers was presented using the variable coherence properties of the semiconductor laser.7 In this technique, they exploited dramatic variations in effective coherence length properties of certain types of laser diodes by simply regulating the input drive current to these devices. For a long coherence length, all photons interfere, while for a short coherence length only photons with almost the same path length will interfere. This will relatively suppress the deep photons, since the (few) deep photons will only interfere with the few deep photons but not with the (many) shallow photons. However, these methods still give no control over the optical path length traveled by the detected light.

Detection of multiple scattered light and its Doppler spectra as a function of path length may result in more quantitative and reliable tissue structural and functional information. Path-length-resolved photon intensity, and the associated Doppler spectra on completely dynamic media, can be measured using low coherence interferometry. 8, 9, 10, 11 Path length distributions in almost static and mixed static-dynamic media can be measured by modulating the optical path length in the reference arm.12 This will enable path-length-resolved measurements in mixed media such as tissue perfused with blood. Furthermore, we validated the optical path length distributions and path-length-dependent diffusion broadening of multiple scattered light with Monte Carlo simulations, and diffusive wave spectroscopy, respectively.13

In this study, we show the first results on path-length-resolved laser Doppler perfusion measurements in skin. For a given optical path length, perfusion was measured in real time before, during, and after an occlusion of the upper arm. In all measurements, perfusion was measured simultaneously with a conventional LDPM.

We use a fiber optic Mach–Zehnder interferometer with a superluminescent diode (Inject LM2-850, λ=832nm , ΔλFWHM=17nm , coherence length LC=18μm ) that yields 2mW of power from the single-mode pigtail fiber as the light source. We use a single-mode fiber ( modefielddiameter=5.3μm , NA=0.14 ) for illumination and multimode graded-index fiber ( corediameter=100μm , NA=0.29 ) for detection with a center-to-center separation of 300μm . The use of multimode fiber provides a large detection window with a small modal dispersion. The reference beam is polarized using a linear polarizer and the phase is sinusoidally modulated at 6kHz using an electro-optic broadband phase modulator (New Focus Model 4002) with a peak optical phase shift of 2.04 radians applied to the modulator, so that the power spectrum contains interference peaks at both the phase modulation frequency and higher harmonics. The AC photocurrent is measured with a 12-bit analog-to-digital converter (National Instruments), sampling at 40 kHz, averaged over 1000 spectra, and was measured in steps of 200μm in air.12, 13, 14

The fundamental output quantity of a LDPM is the first moment of the power spectrum P(ω) of the detector signal; in general, the i ’th moment is being defined as

1

Mi=abP(ω)ωidω.
Here a and b are device dependent low and high cut-off frequencies. With i=0 , a quantity is obtained that is proportional to the concentration of moving red blood cells, while i=1 describes red blood cell flux, which is the product of concentration and the root mean square of the red cell speed, at least for low blood concentrations.15 The conventional LDPM (PF5000, Perimed AB, Sweden) uses a laser diode (780nm) as the light source, a bandwidth of 20Hz to 13kHz [ a and b in Eq. 1], and a time constant of 0.2s was used for monitoring. The fiber optic probe (Probe 408, standard probe) consists of two spatially separated fibers ( corediameter=125μm , NA=0.37 ) with a center-to-center separation of 250μm .

Optical path length distributions are obtained by adding the areas of all interference peaks (after subtraction of the background noise, and within a bandwidth of ±2kHz around all center frequencies) in the power spectrum. The area of the Doppler broadened peak, excluding the statically scattered light contribution at the interference peaks, forms an estimation of the amount of Doppler shifted light at that specific optical path length. The average Doppler shift corresponding to the Doppler shifted light is calculated from the weighted first moments (M1M0) of the heterodyne peak at the modulation frequency, after correction for the homodyne signal from the sample arm (skin) and for the reference arm noise [in a bandwidth of 50Hz to 2kHz close to the phase modulation frequency and its higher harmonics, indicated by a and b in Eq. 2].

2

Mi=j=13jωm+ajωm+bP(ω)(ωjωm)idω.

Path length distribution measurements were performed on the skin of the dorsal side of the right forearm of a dark-skinned healthy human volunteer in the sitting position. The fiber optic probe was inserted into a probe holder (PH 08) that was attached to the skin with a double-sided adhesive tape. The subject rested approximately 10min prior to the measurements. For monitoring the perfusion changes in real time, the signal was sampled at 40kHz for 2.6s to get an average of 100 spectra. Simultaneous measurement of perfusion was performed with the PF5000 at a position approximately 3cm distant to the probe of the low coherence interferometer. The perfusion was recorded for 30s before occlusion, 90s during occlusion, 105s between occlusions, a second occlusion for another 90s , and final measurements for 30s .

We observed that during the arterial occlusion, the broadening of the interference peaks resulting from the Doppler shift imparted by the moving red blood cells to the multiply scattered photons is reduced, whereas the area of the peaks, which represents the intensity of detected photons within a certain optical path length, does not change. The intensity of Doppler shifted and nonshifted photons measured in skin as a function of optical path length are shown in Fig. 1 . The fraction of Doppler shifted photons and nonshifted photons averaged over the entire optical path length measured from the respective areas of the optical path lengths are 22 and 78%, respectively. As shown in Fig. 1, the weighted first moment M1M0 of the Doppler shifted light, which represents the average Doppler shift, increased with the optical path length due to the greater probability of interaction of photons with moving scatterers for large optical path lengths.

Fig. 1

Intensity of Doppler-shifted, nonshifted photons and the average Doppler shift as a function of optical path length measured in skin.

060508_1_053706jbo1.jpg

Figure 2 shows the perfusion signal measured in skin in real time for an optical path length difference of 1.7mm in air. The occlusion results in the suppression of mean flow velocity of red blood cells to nearly zero values (biological zero). The flux of red blood cells (Fig. 2, left, bottom) and the Doppler-shifted fraction of photons are reduced due to occlusion (Fig. 2, left, top). Since the realization of occlusion takes some time, the perfusion decreases gradually and finally drops to biological zero values. After the occlusion is released, the perfusion signal increases above the normal value, an effect called postocclusive reactive hyperemia (PORH). PF5000 traces recorded with a time constant of 0.2s are averaged for the same measurement time used in our measurements (2.6s) . Real-time measurements performed with our setup show similar trends as the perfusion readings measured with the PF5000. However, smoother perfusion signals are shown from the PF5000 compared to the fluctuating perfusion signal obtained with our LCI set up. Although the mean depth is of the order of 1mm , in PF5000, perfusion values averaged over all optical path lengths are measured, which often spans a range of zero to 5mm . In our setup, the coherence length of the light source acts as a bandpass filter in selecting the photons that have traveled a specific optical path length (for instance, 1.7mm ) in the skin with a tolerance of ±50μm , as defined by the path length resolution of the setup. Hence, in a LDPM, due to the large coherence length of the light source, more photons are involved in the interference process, leading to a large signal-to-noise ratio of the raw signal, and a more stable estimation of its spectral moments. The lowest value recorded with PF5000 is relatively lower during occlusion, and the PORH peak with LDPM is shorter in time than with LCI. These variations could result from the fact that both techniques probe different positions (spatial separation of 3cm ) and our probe measures physiological perfusion in the superficial layers (with an optical path length of 1.7mm ) compared to the perfusion averaged over all path lengths and depths. Also, we only have heterodyne detection, while in LDPM the signal power spectrum is composed of mutual interference of the Doppler-shifted and nonshifted light detected from the tissue. Temporal resolution of 2.6s makes it difficult to follow all physiologic changes, such as cardiac cycle and reactive hyperaemia responses. During occlusion, the observed discrepancy between the calibrated zero of the instrument (PF5000) and the “biological zero” level is attributed to the fact that though the blood perfusion is arrested by the inflated cuff, minor Doppler components are recorded by the instrument due to the no-flow laser Doppler signal from vasomotion, Brownian motion from within the vascular compartment and of macromolecules in the inter- and intracellular fluids, and the effects of cuff compression.16 The zero on the vertical scale (Fig. 2, left) represents the calibrated instrumental zero of our instrument. The offset between the perfusion readings during occlusion and the calibrated zero of LCI represents the perfusion signal corresponding to the biological zero for an optical path length difference of 1.7mm . The lowest value recorded with LCI during occlusion is relatively higher compared to PF5000. With an optical path length difference of 1.7mm , perfusion from superficial layers is only measured. Due to the smaller and more shallow measurement volume in LCI for an OPL of 1.7mm , the maximum perfusion within the probed volume is smaller, since fewer vessels are probed. Hence, the maximum perfusion value is relatively lower, which makes the minimum perfusion value during occlusion relatively larger.

Fig. 2

Real-time monitoring of perfusion measured with our setup (left) for an optical path length of 1.7mm and simultaneous measurements with PF5000 (right).

060508_1_053706jbo2.jpg

In this work, we have presented the first path-length-resolved Doppler measurements of multiply scattered light from skin, using a phase-modulated low coherence Mach-Zehnder interferometer with spatially separated fibers for illumination and detection. Optical path length distributions of multiply scattered light, spanning a range of 0 to 5mm , have been measured. The path-length-resolved perfusion measured in real time with our setup, for an optical path length of 1.7mm , and its variations during artery occlusion, showed correlation with the perfusion signal measured using a conventional LDPM. The Doppler-shifted fraction of photons, which is related to the blood volume and the flux of red blood cells measured from the first moment, are decreased during occlusion. In general, the path-length-resolved perfusion measurements presented here will overcome the influence of photon path lengths on the measured perfusion signal, and make it possible to perform depth-resolved perfusion measurements. Also, our method allows us to discriminate between the Doppler-shifted and nonshifted fraction of photons in the detected photodetector signal. Further in vivo studies were performed to measure the variations in perfusion to external stimuli, inter-and intraindividual variations in optical path lengths and path-length-resolved Doppler shifts, and to compare these results with the perfusion signal measured with a conventional LDPM. These results will be reported separately in the near future.

Acknowledgments

This work was sponsored by the Netherlands Technology Foundation STW (Grant TTF 5840) and the Institute for Biomedical Technology of the University of Twente. Perimed AB (Stockholm, Sweden) is acknowledged for providing instrumentation.

References

1.  A. P. Shepherd and P. Å. Öberg, Laser-Doppler Blood Flowmetry, Kluwer Academic, Boston (1990). Google Scholar

2.  A. N. Obeid, D. M. Boggett, N. J. Barnett, G. Dougherty, and P. Rolfe, Med. Biol. Eng. Comput.0140-0118 10.1007/BF02442302 26, 415–419 (1988). Google Scholar

3.  R. J. Gush and T. A. King, Med. Biol. Eng. Comput.0140-0118 10.1007/BF02441659 29, 387–392 (1991). Google Scholar

4.  L. Duteil, J. C. Bernengo, and W. Schalla, IEEE Trans. Biomed. Eng.0018-9294 10.1109/TBME.1985.325452 BME32, 439–447 (1985). Google Scholar

5.  M. Larsson, W. Steenbergen, and T. Strömberg, J. Biomed. Opt.1083-3668 10.1117/1.1463049 7(2), 236–243 (2001). Google Scholar

6.  A. Liebert, M. Leahy, and R. Maniewski, Med. Biol. Eng. Comput.0140-0118 10.1007/BF02518878 36, 740–747 (1998). Google Scholar

7.  G. Dougherty, Rev. Sci. Instrum.0034-6748 10.1063/1.1142584 63, 3220–3221 (1992). Google Scholar

8.  A. Wax, C. Yang, R. R. Dasari, and M. S. Feld, Appl. Opt.0003-6935 10.1364/AO.40.004222 40, 4222–4227 (2001). Google Scholar

9.  K. K. Bizheva, A. M. Siegel, and D. A. Boas, Phys. Rev. E1063-651X 10.1103/PhysRevE.58.7664 58, 7664–7667 (1998). Google Scholar

10.  A. L. Petoukhova, W. Steenbergen, and F. F. M. de Mul, Opt. Lett.0146-9592 10.1364/OL.26.001492 26, 1492–1494 (2001). Google Scholar

11.  D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, C. A. Puliafito, and J. G. Fujimoto, Science0036-8075 10.1126/science.1957169 254, 1178–1181 (1991). Google Scholar

12.  B. Varghese, V. Rajan, T. G. Van Leeuwen, and W. Steenbergen, J. Biomed. Opt.1083-3668 10.1117/1.2714795 12, 024020 (2007). Google Scholar

13.  B. Varghese, V. Rajan, T. G. Van Leeuwen, and W. Steenbergen, Opt. Express1094-4087 10.1364/OE.15.009157 15(15), 9157–9165 (2007). Google Scholar

14.  B. Varghese, V. Rajan, T. G. Van Leeuwen, and W. Steenbergen, (submitted for publication). Google Scholar

15.  G. E. Nilsson, Med. Biol. Eng. Comput.0140-0118 10.1007/BF02442104 22, 343–348 (1984). Google Scholar

16.  D. P. Kernick, J. E. Tooke, and A. C. Shore, Eur. J. Physiol.0031-6768 10.1007/s004240050826 437, 624–631 (1999). Google Scholar

Babu Varghese, Vinayakrishnan Rajan, Ton G. van Leeuwen, Wiendelt Steenbergen, "Path-length-resolved optical Doppler perfusion monitoring," Journal of Biomedical Optics 12(6), 060508 (1 November 2007). http://dx.doi.org/10.1117/1.2823141
JOURNAL ARTICLE
3 PAGES


SHARE
KEYWORDS
Doppler effect

Tissue optics

Photons

Skin

Blood

Light scattering

Optical fibers

RELATED CONTENT


Back to Top